Sign In | Create an Account | Welcome, . My Account | Logout | Subscribe | Submit News | Contact Us | All Access E-Edition | Home RSS

Big Pharma’s ‘Pay for Delay’ Eyed

Supreme Court weighs incentives paid to makers of generic drugs

March 25, 2013
By JESSE J. HOLLAND - Associated Press , The Intelligencer / Wheeling News-Register

WASHINGTON - Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs. They argue these deals deny American consumers, usually for years, steep price declines that can top 90 percent.

I am looking for: